Patricia Simpson, LCPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 3175 West Ward Road, 200, Dunkirk, MD 20754 Phone: 410-286-0664 Fax: 410-286-2834 |
Mrs. Barbara June Ferrenz, LCPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 10363 Southern Maryland Blvd, Dunkirk, MD 20754 Phone: 410-286-8188 Fax: 410-286-8188 |
Ms. Patsy Winona Mengiste, LGP Counselor Medicare: Not Enrolled in Medicare Practice Location: 11275 Southern Maryland Blvd, Dunkirk, MD 20754 Phone: 180-049-1526 |
Ashley Thorne Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 10339 Southern Maryland Blvd Ste 209, Dunkirk, MD 20754 Phone: 301-327-5417 |
Erin Monfiston, LCPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 3175 W Ward Rd Ste 200, Dunkirk, MD 20754 Phone: 410-286-0664 Fax: 410-286-2834 |
Amanda Peterson, LGPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 10339 Southern Maryland Blvd Ste 209, Dunkirk, MD 20754 Phone: 301-327-5417 |
Paula K Newsome, LGPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 10339 Southern Maryland Blvd, Suite 205, Dunkirk, MD 20754 Phone: 443-295-3412 |
Ladonna Johnson, LCPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 11275 Southern Maryland Blvd, Dunkirk, MD 20754 Phone: 406-788-4968 |
News Archive
In Thursday night's debate, Vice President Joe Biden will almost certainly go after Representative Paul Ryan's Medicare plan. And why shouldn't he? It's unpopular. But I'd like to make a case for that plan. It's the best thing the Romney-Ryan campaign has going for it.
A team of international researchers may have identified a new way to control mosquito-borne illnesses, according to a new study published in the journal Nature Communications.
Merck today announced that final results from two pivotal Phase III studies of boceprevir, its investigational oral hepatitis C protease inhibitor, will be presented in oral plenary sessions at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), which is taking place from Oct. 29 through Nov. 2 in Boston. Results for boceprevir in response-guided therapy strategies, which evaluated treatment durations shorter than current standard therapy, will be presented during the meeting.
Forest Laboratories, and Pierre Fabre Medicament today announced preliminary top-line results from a Phase III study of levomilnacipran for the treatment of major depressive disorder.
An inflammatory protein that triggers a pregnant mouse's immune response to an infection or other disease appears to cause brain injury in her fetus, but not the premature birth that was long believed to be linked with such neurologic damage in both rodents and humans, new Johns Hopkins-led research suggests.
› Verified 2 days ago